Hematologic Malignancies
Showing NaN - NaN of 7
Hematologic Malignancies Trial in United States (IPI-145 (duvelisib))
Terminated
- Hematologic Malignancies
- IPI-145 (duvelisib)
-
New York, New York
- +3 more
Mar 15, 2021
Advanced Solid Malignancies, Hematologic Malignancies Trial in Fort Myers, Oklahoma City, Nashville (MLN0128, paclitaxel,
Completed
- Advanced Solid Malignancies
- Hematologic Malignancies
- MLN0128
- +2 more
-
Fort Myers, Florida
- +2 more
Jun 28, 2019
Solid Tumor, Hematologic Malignancies Trial in United States (BGJ398)
Terminated
- Solid Tumor
- Hematologic Malignancies
-
Birmingham, Alabama
- +55 more
May 28, 2019
Chronic Myelogenous Leukemia, Hematologic Malignancies Trial in United States (Ponatinib)
Completed
- Chronic Myelogenous Leukemia
- Hematologic Malignancies
-
San Francisco, California
- +4 more
May 15, 2018